<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>TEDE Collection:</title>
  <link rel="alternate" href="https://tede.unioeste.br/handle/tede/515" />
  <subtitle />
  <id>https://tede.unioeste.br/handle/tede/515</id>
  <updated>2026-08-07T06:00:32Z</updated>
  <dc:date>2026-08-07T06:00:32Z</dc:date>
  <entry>
    <title>Fórmulas infantis prebióticas: caracterização físico-química, microbiológica e verificação do efeito prebiótico</title>
    <link rel="alternate" href="https://tede.unioeste.br/handle/tede/8588" />
    <author>
      <name>Soares, Mykelli De Andrade Santos</name>
    </author>
    <id>https://tede.unioeste.br/handle/tede/8588</id>
    <updated>2026-08-05T19:15:31Z</updated>
    <published>2026-07-28T00:00:00Z</published>
    <summary type="text">Title: Fórmulas infantis prebióticas: caracterização físico-química, microbiológica e verificação do efeito prebiótico
Autor: Soares, Mykelli De Andrade Santos
Primeiro orientador: Bernardi, Daniela Miotto
Abstract: Infant formulas (IF) constitute an important nutritional alternative for infants when &#xD;
breastfeeding is not possible, making it essential to ensure their physicochemical, &#xD;
microbiological, and functional quality. This study aimed to characterize prebiotic infant &#xD;
formulas intended for infants aged 0 to 6 months regarding their physicochemical &#xD;
composition, microbiological quality, and their ability to stimulate probiotic growth in &#xD;
vitro. Three commercial brands of IF supplemented with fructooligosaccharides (FOS) &#xD;
and galactooligosaccharides (GOS), acquired from retail stores in Cascavel, Paraná, &#xD;
Brazil, were evaluated. Physicochemical and microbiological analyses were performed &#xD;
on powdered and reconstituted formulas immediately after the package was opened &#xD;
and after storage periods at room temperature. The growth of Lactobacillus acidophilus &#xD;
in media supplemented with these formulas was also evaluated. The results &#xD;
demonstrated that the IF presented centesimal composition within the limits &#xD;
established by Brazilian legislation, although significant differences among brands and &#xD;
batches were observed in some parameters. Microbiological analyses showed the &#xD;
absence of pathogenic microorganisms of sanitary relevance, indicating satisfactory &#xD;
microbiological safety conditions throughout the evaluated period. A slight increase in &#xD;
mesophilic aerobic counts was observed during storage of the reconstituted formulas; &#xD;
however, the values remained within acceptable standards. Formulas supplemented &#xD;
with prebiotics promoted the growth of Lactobacillus acidophilus, demonstrating a &#xD;
potential in vitro prebiotic effect. It was concluded that the evaluated prebiotic infant &#xD;
formulas presented satisfactory physicochemical and microbiological quality, in &#xD;
addition to functional potential related to the stimulation of beneficial bacterial growth, &#xD;
reinforcing their importance as a nutritional alternative for infants.
Publisher: Universidade Estadual do Oeste do Paraná
Tipo do documento: Dissertação</summary>
    <dc:date>2026-07-28T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Desenvolvimento de complexos de inclusão bosentana-ciclodextrina e avaliação das características biofarmacêuticas.</title>
    <link rel="alternate" href="https://tede.unioeste.br/handle/tede/8580" />
    <author>
      <name>Webler, Emanuelle Menegazzo</name>
    </author>
    <id>https://tede.unioeste.br/handle/tede/8580</id>
    <updated>2026-08-03T18:54:54Z</updated>
    <published>2015-12-09T00:00:00Z</published>
    <summary type="text">Title: Desenvolvimento de complexos de inclusão bosentana-ciclodextrina e avaliação das características biofarmacêuticas.
Autor: Webler, Emanuelle Menegazzo
Primeiro orientador: Rosa, Mauricio Ferreira da
Abstract: Pulmonary hypertension is a condition that affects the respiratory &#xD;
system, causing fatigue and exercise intolerance. In addition to being an &#xD;
incurable disease, its evolution is fast, and there are few effective options for &#xD;
treatment. The need for drugs to treat this disease and the growing interest of &#xD;
the medical class the knowledge of this disease prompted the study in this area, &#xD;
in order to search for therapeutic enhancement of currently available drugs for &#xD;
the treatment of pulmonary arterial hypertension. Because the bosentan a low &#xD;
solubility and bioavailability of drug, is interesting that pharmacotechnical &#xD;
methods are developed to provide improved absorption of this drug and &#xD;
potentiation of pharmacological activity of the therapeutic dose approved for the &#xD;
treatment of pulmonary hypertension. One of the available techniques for &#xD;
improving solubility and bioavailability of drugs is complexation with &#xD;
cyclodextrins used successfully in low aqueous solubility drugs. Thus, the &#xD;
intention of developing bosentan inclusion complexes with cyclodextrins is to &#xD;
promote better therapeutic use, increasing the effectiveness of the &#xD;
pharmacological treatment of patients with pulmonary hypertension. This &#xD;
research proposes the formation of bosentan inclusion complexes and &#xD;
cyclodextrins to increase drug solubility and improve the bioavailability of the &#xD;
drug, providing a differentiated ability to potentiate the treatment of pulmonary &#xD;
hypertension, can promote drug absorption, by optimizing the therapeutic effect &#xD;
and improving the quality of life of patients. The inclusion complex was &#xD;
prepared by several techniques, in solution, by physical mixing and spray-drier, &#xD;
evaluating the physico-chemical changes and characterization of the complex &#xD;
through the kinetic techniques, the stoichiometry of complexation, the solubility &#xD;
isotherms, spectrophotometry UV-VIS, solubility, DSC, TGA, infrared &#xD;
spectroscopy, electron microscopy in bright field and polarized light, apparent &#xD;
dissolution and dissolution profile. The results showed the formation of the &#xD;
inclusion complex due to changes in the characteristic peaks of the raw &#xD;
materials and increasing solubility, taking into consideration the conditions &#xD;
evaluated. The inclusion complex showed higher water solubility that the &#xD;
isolated bosentan, reinforcing the possibility that a formulation with the inclusion &#xD;
complex may have greater bioavailability in the organism.
Publisher: Universidade Estadual do Oeste do Paraná
Tipo do documento: Dissertação</summary>
    <dc:date>2015-12-09T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Suplementos Alimentares: aspectos legais, sanitários e os riscos à saúde pública.</title>
    <link rel="alternate" href="https://tede.unioeste.br/handle/tede/8577" />
    <author>
      <name>Spohr, Franciele Carline</name>
    </author>
    <id>https://tede.unioeste.br/handle/tede/8577</id>
    <updated>2026-07-31T14:45:48Z</updated>
    <published>2026-05-22T00:00:00Z</published>
    <summary type="text">Title: Suplementos Alimentares: aspectos legais, sanitários e os riscos à saúde pública.
Autor: Spohr, Franciele Carline
Primeiro orientador: Fariña, Luciana Oliveira de
Abstract: This dissertation aimed to analyze the legislative compliance of the &#xD;
commercialization of dietary supplements based on medicinal plants requiring &#xD;
medical prescription, according to the Herbal Formulary of the Brazilian &#xD;
Pharmacopoeia, marketed in grain stores and natural product shops in the &#xD;
municipality of Medianeira, Western Paraná, Brazil. The study was based on the &#xD;
hypothesis that products containing substances with pharmacological potential were &#xD;
being marketed as dietary supplements, often in disagreement with current health &#xD;
regulations, potentially posing risks to public health, especially in situations requiring &#xD;
medical prescription and professional monitoring. Despite the increasing &#xD;
consumption of dietary supplements and herbal products in Brazil, their integration &#xD;
into clinical practice and the regulatory context still showed limitations and challenges &#xD;
related to safety, inspection, and rational use. &#xD;
The research adopted a qualitative and quantitative approach through literature &#xD;
review and a descriptive observational field study. Aspects related to labeling, &#xD;
regulatory classification, therapeutic claims, presence of medicinal plant mixtures, &#xD;
and commercialization practices of the identified products were evaluated. The level &#xD;
of knowledge of the establishment managers regarding the regulations applicable to &#xD;
dietary supplements and medicinal plants was also analyzed. &#xD;
The results revealed the commercialization of products containing medicinal plants &#xD;
requiring medical prescription presented as dietary supplements, as well as the &#xD;
presence of nonconformities related to labeling, sanitary designation, and regulatory &#xD;
classification. The offer of substances requiring medical prescription without proper &#xD;
professional guidance was also identified. In addition, therapeutic claims potentially &#xD;
incompatible with the regulatory category of dietary supplements were observed. &#xD;
These findings demonstrated weaknesses in compliance with current health &#xD;
legislation and gaps in technical knowledge regarding the use of medicinal plants and &#xD;
dietary supplements. &#xD;
The study also highlighted the importance of strengthening regulation, intensifying &#xD;
health surveillance actions, and promoting appropriate guidance for both &#xD;
establishment owners and consumers, aiming to encourage the rational use and &#xD;
responsible commercialization of these products, which are often perceived as &#xD;
“natural” and therefore risk-free, although this perception does not always reflect &#xD;
reality.
Publisher: Universidade Estadual do Oeste do Paraná
Tipo do documento: Dissertação</summary>
    <dc:date>2026-05-22T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Uma breve revisão: aspectos metodológicos e estruturais de peptídeos antimicrobianos (PAMs) de fungos filamentosos e suas aplicações biotecnológicas.</title>
    <link rel="alternate" href="https://tede.unioeste.br/handle/tede/8576" />
    <author>
      <name>Zismann, Samuel Angelo</name>
    </author>
    <id>https://tede.unioeste.br/handle/tede/8576</id>
    <updated>2026-07-31T13:54:33Z</updated>
    <published>2021-12-07T00:00:00Z</published>
    <summary type="text">Title: Uma breve revisão: aspectos metodológicos e estruturais de peptídeos antimicrobianos (PAMs) de fungos filamentosos e suas aplicações biotecnológicas.
Autor: Zismann, Samuel Angelo
Primeiro orientador: Silva, José Luis da Conceição
Abstract: Antimicrobial peptides (AMPs) are small proteins that have activity against invaders &#xD;
or that compete for the same survival environment. AMPs are usually composed of &#xD;
10 to 50 amino acids, with an overall positive charge, ranging from +2 to +11, most &#xD;
often in the α-helix or ẞ-sheet conformation. Among similar producers are &#xD;
filamentous fungi, the phylum Ascomycota possesses the majority of producers. The &#xD;
production of AMPs (called AFPs) by the genus Aspergillus and Penicillium stands &#xD;
out. Studies have been undertaken with the purpose of growing the levels of AFPs &#xD;
production and its expression, in a way that is possible to evaluate the molecules &#xD;
structurally and to understand the factors that lead to biological activity. This work &#xD;
aimed to present, through literature review, the biochemical characteristics, the &#xD;
techniques of production, and purification of the main AFP, produced by filamentous &#xD;
fungus described in the literature, with emphasis on Aspergillus and Penicillium &#xD;
genera, as well as the application of these proteins. A search for articles and &#xD;
information was carried out in the PubMed database, Portal de Periódicos da Capes &#xD;
and Proteins of the National Center of Biotechnology Information (NCBI), retrieving &#xD;
articles between the period of 1965 and 2021. Currently, there is a production of AFP &#xD;
by culturing the organism in a specific culture media that induces the fungus to the &#xD;
desired product, and by means of an expression system based on the P. &#xD;
chrysogenum. The purification of the peptides occurs mainly through &#xD;
chromatographic techniques, usually ion exchange due to the cationic nature of the &#xD;
peptides. Once produced and purified, AFPs have the possibility of being explored in &#xD;
terms of their structure and application. The chitin-binding sequence (in peptides of &#xD;
Aspergillus genus), the γ-core motif, the disulfide bonds and the positive charge are &#xD;
highlighted as key structures of these molecules, allowing the use of these proteins in &#xD;
the fight against fungal infection in agriculture and in the human body. Since the &#xD;
difficulty in isolating AFPs due to the lack of expression of these molecules or the &#xD;
expression at low levels seems to have been overcome by genetic engineering, &#xD;
possibly the transition to in vivo and large-scale studies is the biggest challenge &#xD;
today, since the studies for the application of AFPs remain at the laboratory level (in &#xD;
vitro), wich requires not only studies that elucidate the structure and function of these &#xD;
proteins, but also efforts that allow the arrival of AFPs in the industry.
Publisher: Universidade Estadual do Oeste do Paraná
Tipo do documento: Dissertação</summary>
    <dc:date>2021-12-07T00:00:00Z</dc:date>
  </entry>
</feed>

